02096 SIMCERE PHARMA
- 5.760
- -0.060-1.03%
SIMCERE PHARMA News
The medical news is huge! Will Pharmacokinetics usher in a turning point? US pharmaceutical company contract exemption or extension for 8 years
Industry insiders believe that 8 years is enough time for relevant companies to adapt, and the implementation of this greatest uncertainty can also have a positive impact on related companies.
May 10 repurchase collection | HSBC Holdings, Hang Seng Bank, etc. are buying back one after another, of which HSBC Holdings spent HK$218 million
According to HKEx disclosure documents on May 13, $HSBC Holdings (00005.HK) $ and $Hang Seng Bank (00011.HK) $ repurchased shares. ① $HSBC Holdings (00005.HK) $ repurchased 3.2 million common shares on May 9, involving an amount of HK$218 million. The repurchase price per share ranged from HK$68.5 to HK$67.55. ② $Hang Seng Bank (00011.HK) $ repurchased 300,000 common shares on May 10, involving an amount of HK$32.3702 million. The repurchase price per share ranged from HK$109.1 to HK$106.3
Xiansheng Pharmaceutical (02096.HK) spent HK$5.226,400 to repurchase 904,000 shares on May 10
Gelonghui May 10 | Xiansheng Pharmaceutical (02096.HK) issued an announcement. On May 10, 2024, it spent HK$5.226,400 to repurchase 904,000 shares at a repurchase price of HK$5.71-5.82 per share.
May 9 repurchase collection | HSBC Holdings, Hang Seng Bank, etc. are buying back one after another, of which HSBC Holdings spent HK$218 million
According to HKEx disclosure documents on May 10, $HSBC Holdings (00005.HK) $ and $Hang Seng Bank (00011.HK) $ repurchased shares. ① $HSBC Holdings (00005.HK) $ repurchased 3,09.76 million common shares on May 8, involving an amount of HK$218 million. The repurchase price per share ranged from HK$70.65 to HK$70.25. ② $Hang Seng Bank (00011.HK) $ repurchased 300,000 common shares on May 9, involving an amount of HK$319.023 million. The repurchase price per share ranged from HK$107.5 to HK$105
Xiansheng Pharmaceutical (02096.HK) spent HK$3.94 million to buy back 680,000 shares on May 9
Gelonghui, May 9, 丨 Xiansheng Pharmaceutical (02096.HK) issued an announcement. On May 9, 2024, it spent HK$3.94 million to repurchase 680,000 shares at a repurchase price of HK$5.78-5.8 per share.
May 8 Repurchase Collection | Hang Seng Bank, Swire Group A and others bought back one after another. Of these, Hang Seng Bank spent HK$32.0953 million
According to documents disclosed by the Hong Kong Stock Exchange on May 9, $Hang Seng Bank (00011.HK) $ and $Swire Group A (00019.HK) $ repurchased shares. ① $Hang Seng Bank (00011.HK) $ repurchased 300,000 common shares on May 8, involving an amount of HK$32.0953 million. The repurchase price per share ranged from HK$107.7 to HK$106. The cumulative number of securities repurchased during the year (since the adoption of the ordinary resolution) is 300,000 shares, accounting for 0.016% of the number of shares issued when the ordinary resolution was passed. ② $Swire Group A
Xiansheng Pharmaceutical (02096) spent about HK$8.3287 million to buy back 1.454 million shares on May 8
Xiansheng Pharmaceutical (02096) announced that on May 8, 2024, it spent approximately HK$8.328,700 to repurchase 1.454 million shares at a repurchase price of HK$5.68-5.75 per share.
May 7 Repurchase Collection | Kuaishou-W, Hang Seng Bank and others bought back one after another, of which Kuaishou-W cost HK$49.499 million
According to documents disclosed by the Hong Kong Stock Exchange on May 8, $Kuaishou-W (01024.HK) $, $Hang Seng Bank (00011.HK) $, etc. repurchased shares. ① $Kuaishou-W (01024.HK) $ repurchased 844,000 shares of the same share with different rights on May 7, involving an amount of HK$49.499 million. The repurchase price for each share ranged from HK$59.95 to HK$58.5. The cumulative number of securities repurchased during the year (since the adoption of the ordinary resolution) is 58.722,300 shares, accounting for 1.355% of the number of shares issued when the ordinary resolution was passed. ②
Featured announcements | Zhonghai Real Estate's sales fell 30% year on year; Shangtang plans to build a joint venture to build a big data computing power platform
Guolian Securities: Major asset restructuring is still in the planning stage; Sunac China: cumulative contract sales in the first 4 months were 22.45 billion yuan, a year-on-year decrease of 39.86%.
Xiansheng Pharmaceutical (02096.HK) spent HK$10.4854 million to buy back 1.843 million shares on May 7
Gelonghui on May 7, 丨 Xiansheng Pharmaceutical (02096.HK) issued an announcement. On May 7, 2024, it spent HK$10.485,400 to repurchase 1,843 million shares at a repurchase price of HK$5.64-5.71 per share.
Express News | Guotai Junan: Pharmaceutical industry prosperity is expected to continue to improve
May 6 Repurchase Collection | Hang Seng Bank, Swire Group A, etc. bought back one after another. Of these, Hang Seng Bank spent HK$36.803 million
According to HKEx disclosure documents on May 7, $Hang Seng Bank (00011.HK) $ and $Swire Group A (00019.HK) $ repurchased shares. ① $Hang Seng Bank (00011.HK) $ repurchased 350,000 common shares on May 6, involving an amount of HK$36.803 million. The repurchase price for each share ranged from HK$105.7 to HK$104.7. The cumulative number of securities repurchased during the year (since the adoption of the ordinary resolution) is 8.734 million shares, accounting for 0.457% of the number of shares issued when the ordinary resolution was passed. ② $Taikoo Shares
Xiansheng Pharmaceutical (02096) spent HK$4.952,500 to buy back 870,000 shares on May 6
According to the Zhitong Finance App, Xiansheng Pharmaceutical (02096) announced that on May 6, 2024, the company spent HK$4.952,500 to repurchase 870,000 shares at a repurchase price of HK$5.68-5.71 per share.
May 3 Repurchase Collection | Hang Seng Bank, Swire Group A and others bought back one after another. Of these, Hang Seng Bank spent HK$42.1266 million
According to documents disclosed by the Hong Kong Stock Exchange on May 6, $Hang Seng Bank (00011.HK) $ and $Swire Group A (00019.HK) $ repurchased shares. ① $Hang Seng Bank (00011.HK) $ repurchased 400,000 common shares on May 3, involving an amount of HK$42.1266 million. The repurchase price per share ranged from HK$106.2 to HK$104.6. The cumulative number of securities repurchased during the year (since the adoption of the ordinary resolution) is 8.384 million shares, accounting for 0.439% of the number of shares issued when the ordinary resolution was passed. ② $Taikoo
Xiansheng Pharmaceutical (02096) spent HK$781,600 to buy back 138,000 shares on May 3
According to the Zhitong Finance App, Xiansheng Pharmaceutical (02096) announced that on May 3, 2024, the company spent HK$781,600 to repurchase 138,000 shares at a repurchase price of HK$5.64-5.67 per share.
Repurchase Collection on April 30 | Hang Seng Bank, Swire Group A, etc. bought back one after another. Of these, Hang Seng Bank spent HK$56.2511 million
According to documents disclosed by the Hong Kong Stock Exchange on May 2, $Hang Seng Bank (00011.HK) $ and $Swire Group A (00019.HK) $ repurchased shares. ① $Hang Seng Bank (00011.HK) $ repurchased 540,000 common shares on April 30, involving an amount of HK$56.2511 million. The repurchase price per share ranged from HK$105 to HK$103.6. The cumulative number of securities repurchased during the year (since the adoption of the ordinary resolution) is 7.534 million shares, accounting for 0.394% of the number of shares issued when the ordinary resolution was passed. ② $Taikoo Shares
Xiansheng Pharmaceutical (02096.HK) spent HK$1,457,800 to repurchase 270,000 shares on April 30
Gelonghui, April 30 | Xiansheng Pharmaceutical (02096.HK) announced that it spent HK$1.457,800 to repurchase 270,000 shares on April 30.
Repurchase Collection on April 29 | Hang Seng Bank, Swire Group A, etc. bought back one after another. Of these, Hang Seng Bank spent HK$71.0297 million
According to HKEx's April 30 disclosure documents, $Hang Seng Bank (00011.HK) $ and $Swire Group A (00019.HK) $ repurchased shares. ① $Hang Seng Bank (00011.HK) $ repurchased 680,000 common shares on April 29, involving an amount of HK$71.0297 million. The repurchase price per share ranged from HK$104.9 to HK$102.8. The cumulative number of securities repurchased during the year (since the adoption of the ordinary resolution) is 6.994 million shares, accounting for 0.366% of the number of shares issued when the ordinary resolution was passed. ② $
Selected announcements | BYD's net profit for the first quarter increased by nearly 11% year-on-year; CNPC's profit for the first quarter exceeded 45 billion yuan
ICBC's first quarter revenue fell nearly 3% year on year; Vanke Enterprise's first quarter revenue fell by more than 10% year on year.
Xiansheng Pharmaceutical (02096.HK) spent HK$8.922 million to buy back 1.654 million shares on April 29
Xiansheng Pharmaceutical (02096.HK) announced that on April 29, 2024, the company spent HK$8.922,200 to repurchase 1,654 million shares at a repurchase price of HK$5.37-5.44 per share.
Analysis
Price Target
No Data
